Topcon Healthcare Unveils TERA Dry Eye Imager for Dry Eye Diagnosis and Management
Topcon Healthcare introduced the TERA Dry Eye Imager, a multimodal platform designed to detect, grade, and manage dry eye disease (DED). By combining robotic automation with high-resolution imaging, TERA streamlines exams, standardizes image capture, and empowers eye care professionals to deliver precise, patient-centered care.
TERA is designed to simplify dry eye pretesting and features:
One-touch automated alignment, focus, and capture, supported by eye tracking where applicable, reduces variability and staff training time
Guided focus for meibography and tear meniscus height ensures consistent, high-quality images
A rotatable monitor, operable from either side of the patient, enhances ergonomics and optimizes pre-test space, improving overall patient flow
According to Topcon, these features help clinics increase patient throughput without compromising diagnostic precision.
With its advanced optics and patented diffused white light technology, TERA provides sharper, noninvasive views of the ocular surface and tear film lipid layer. The platform integrates corneal topography, pupillometry, and a dedicated dry eye suite with validated grading scales such as Efron, JENVIS, and Meiboscale. Aligned with the TFOS DEWS III diagnostic framework,¹ TERA combines patient-reported symptoms (e.g., OSDI-6) with objective measures like noninvasive tear break-up time (NIBUT), ocular surface staining, and meibography.
According to Topcon, TERA transforms diagnostic data into a personalized, visual conversation that patients can understand, facilitating discussions about treatment options such as intense pulsed light (IPL) and radiofrequency (RF).
“Dry eye care is no longer just about diagnosis; it is about building a service that patients understand and value,” said Rupe Hansra, OD, Vice President of Professional Affairs at Topcon Healthcare, Inc. “TERA helps practices stand out by combining advanced imaging with tools that improve patient education and treatment discussions, creating both better outcomes for patients and new opportunities for practice growth.”
Reference:
1. TFOS DEWS III: Diagnostic Methodology, American Journal of Ophthalmology, May 30, 2025. doi:10.1016/j.ajo.2025.05.033